(WLYB) John Wiley & Sons - Ratings and Ratios
Journals, Books, Digital Courseware, Research Solutions, Training
WLYB EPS (Earnings per Share)
WLYB Revenue
Description: WLYB John Wiley & Sons
John Wiley & Sons, Inc. is a global research and learning company that operates through three segments: Research, Learning, and Held for Sale or Sold, providing a range of products and services to various customers, including learned societies, researchers, professionals, and students.
The companys Research segment is a significant player in the scientific, technical, and medical publishing industry, offering journals, related content, and services to academic, corporate, and government libraries, as well as individual researchers and professionals. Its online publishing platform, Research Solutions, provides a range of services, including content hosting, submissions, and peer review support.
In addition to its research offerings, the company also provides academic and professional products and services, including print and digital books, digital courseware, and online learning solutions to libraries, corporations, students, professionals, and researchers. Its Learning segment provides learning, development, publishing, and assessment services to businesses and professionals, as well as online learning and training solutions for global corporations and small and medium-sized enterprises.
From a financial perspective, John Wiley & Sons, Inc. has a Market Cap of $2.4 billion, indicating a moderate size. Its P/E ratio of 29.68 suggests that the stock may be slightly overvalued, while its Forward P/E of 10.80 indicates potential for future earnings growth. The companys Return on Equity (RoE) of 11.58% is a respectable metric, indicating that the company is generating profits from shareholder equity. Other key performance indicators (KPIs) to consider include Revenue Growth, Operating Margin, and Debt-to-Equity ratio, which can provide further insights into the companys financial health and operational efficiency.
To further analyze the companys performance, we can examine its revenue diversification across different segments and geographies. The companys presence in various markets, including scientific, technical, and medical publishing, as well as its online learning and training solutions, provides a diversified revenue stream. Additionally, its customer base, including learned societies, researchers, professionals, and students, is diverse and widespread. By examining these factors, we can gain a more comprehensive understanding of John Wiley & Sons, Inc.s strengths, weaknesses, and potential opportunities for growth.
Additional Sources for WLYB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
WLYB Stock Overview
Market Cap in USD | 2,412m |
Sector | Communication Services |
Industry | Publishing |
GiC Sub-Industry | Movies & Entertainment |
IPO / Inception | 2022-04-01 |
WLYB Stock Ratings
Growth Rating | 30.5 |
Fundamental | 16.2 |
Dividend Rating | 59.5 |
Rel. Strength | -18.2 |
Analysts | - |
Fair Price Momentum | 42.51 USD |
Fair Price DCF | 289.51 USD |
WLYB Dividends
Dividend Yield 12m | 3.34% |
Yield on Cost 5y | 4.45% |
Annual Growth 5y | 0.58% |
Payout Consistency | 97.8% |
Payout Ratio | 4.9% |
WLYB Growth Ratios
Growth Correlation 3m | 7.6% |
Growth Correlation 12m | 67.7% |
Growth Correlation 5y | 7.8% |
CAGR 5y | 14.69% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | -0.07 |
Alpha | 51.91 |
Beta | 0.227 |
Volatility | % |
Current Volume | 0.4k |
Average Volume 20d | 0.4k |
As of July 03, 2025, the stock is trading at USD 44.16 with a total of 432 shares traded.
Over the past week, the price has changed by +1.26%, over one month by +14.55%, over three months by -0.71% and over the past year by +2.21%.
Neither. Based on ValueRay´s Fundamental Analyses, John Wiley & Sons is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 16.15 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of WLYB is around 42.51 USD . This means that WLYB is currently overvalued and has a potential downside of -3.74%.
John Wiley & Sons has no consensus analysts rating.
According to our own proprietary Forecast Model, WLYB John Wiley & Sons will be worth about 45.9 in July 2026. The stock is currently trading at 44.16. This means that the stock has a potential upside of +3.96%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 45.9 | 4% |